

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.97333268 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.80773814 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.51999219 |
| 4 | vocalization behavior (GO:0071625) | 5.17411475 |
| 5 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 5.16468375 |
| 6 | positive regulation of synapse maturation (GO:0090129) | 5.03686762 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.02411430 |
| 8 | protein localization to synapse (GO:0035418) | 5.00602113 |
| 9 | synaptic vesicle maturation (GO:0016188) | 5.00015047 |
| 10 | glutamate secretion (GO:0014047) | 4.94760238 |
| 11 | glutamate receptor signaling pathway (GO:0007215) | 4.92237423 |
| 12 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.92125275 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.83397436 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.81954653 |
| 15 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.75972490 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.71363943 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.68244887 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.67935554 |
| 19 | response to pheromone (GO:0019236) | 4.66874855 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 4.65958436 |
| 21 | locomotory exploration behavior (GO:0035641) | 4.50756588 |
| 22 | regulation of synapse structural plasticity (GO:0051823) | 4.43155409 |
| 23 | cellular potassium ion homeostasis (GO:0030007) | 4.40000299 |
| 24 | neuron-neuron synaptic transmission (GO:0007270) | 4.35064545 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 4.32199716 |
| 26 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.20391922 |
| 27 | regulation of synaptic vesicle transport (GO:1902803) | 4.16596910 |
| 28 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.12213980 |
| 29 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.08927294 |
| 30 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.04711485 |
| 31 | behavioral fear response (GO:0001662) | 4.03707194 |
| 32 | behavioral defense response (GO:0002209) | 4.03707194 |
| 33 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 4.01938591 |
| 34 | neurotransmitter secretion (GO:0007269) | 4.01699105 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.00016233 |
| 36 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.96706328 |
| 37 | regulation of synapse maturation (GO:0090128) | 3.96590222 |
| 38 | response to histamine (GO:0034776) | 3.95944363 |
| 39 | exploration behavior (GO:0035640) | 3.95579042 |
| 40 | synaptic vesicle endocytosis (GO:0048488) | 3.95326702 |
| 41 | righting reflex (GO:0060013) | 3.94487582 |
| 42 | gamma-aminobutyric acid transport (GO:0015812) | 3.94043936 |
| 43 | long-term synaptic potentiation (GO:0060291) | 3.92027329 |
| 44 | neuronal action potential propagation (GO:0019227) | 3.90578529 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.87239536 |
| 46 | innervation (GO:0060384) | 3.81958644 |
| 47 | auditory behavior (GO:0031223) | 3.80925681 |
| 48 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.74789003 |
| 49 | positive regulation of membrane potential (GO:0045838) | 3.73902354 |
| 50 | striatum development (GO:0021756) | 3.72521793 |
| 51 | membrane depolarization during action potential (GO:0086010) | 3.71937752 |
| 52 | long-term memory (GO:0007616) | 3.69507498 |
| 53 | regulation of postsynaptic membrane potential (GO:0060078) | 3.67749453 |
| 54 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.66182801 |
| 55 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.66025644 |
| 56 | negative regulation of mast cell activation (GO:0033004) | 3.63463570 |
| 57 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.62365245 |
| 58 | behavioral response to nicotine (GO:0035095) | 3.60635835 |
| 59 | fear response (GO:0042596) | 3.59302712 |
| 60 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.54465614 |
| 61 | neuronal action potential (GO:0019228) | 3.54137434 |
| 62 | sodium ion export (GO:0071436) | 3.54073761 |
| 63 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.52730242 |
| 64 | protein localization to cilium (GO:0061512) | 3.51990079 |
| 65 | regulation of synaptic plasticity (GO:0048167) | 3.48225940 |
| 66 | neuron recognition (GO:0008038) | 3.47065310 |
| 67 | mating behavior (GO:0007617) | 3.43648590 |
| 68 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.42624366 |
| 69 | nucleobase catabolic process (GO:0046113) | 3.41906035 |
| 70 | seminiferous tubule development (GO:0072520) | 3.41779235 |
| 71 | regulation of neurotransmitter secretion (GO:0046928) | 3.41008431 |
| 72 | membrane hyperpolarization (GO:0060081) | 3.40413043 |
| 73 | neurotransmitter transport (GO:0006836) | 3.39140641 |
| 74 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.36058656 |
| 75 | regulation of vesicle fusion (GO:0031338) | 3.34649562 |
| 76 | membrane depolarization (GO:0051899) | 3.34604568 |
| 77 | presynaptic membrane assembly (GO:0097105) | 3.34399070 |
| 78 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.31852886 |
| 79 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.31852886 |
| 80 | cellular sodium ion homeostasis (GO:0006883) | 3.31195659 |
| 81 | prepulse inhibition (GO:0060134) | 3.30099442 |
| 82 | synaptic transmission (GO:0007268) | 3.29084657 |
| 83 | layer formation in cerebral cortex (GO:0021819) | 3.27742331 |
| 84 | DNA deamination (GO:0045006) | 3.27503736 |
| 85 | dendritic spine morphogenesis (GO:0060997) | 3.27236653 |
| 86 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.26808238 |
| 87 | regulation of neurotransmitter transport (GO:0051588) | 3.26376151 |
| 88 | fucose catabolic process (GO:0019317) | 3.24053987 |
| 89 | L-fucose metabolic process (GO:0042354) | 3.24053987 |
| 90 | L-fucose catabolic process (GO:0042355) | 3.24053987 |
| 91 | cell communication by electrical coupling (GO:0010644) | 3.23311986 |
| 92 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.21791038 |
| 93 | detection of light stimulus involved in visual perception (GO:0050908) | 3.21791038 |
| 94 | transmission of nerve impulse (GO:0019226) | 3.19617155 |
| 95 | aggressive behavior (GO:0002118) | 3.16772554 |
| 96 | learning (GO:0007612) | 3.15331981 |
| 97 | synapse assembly (GO:0007416) | 3.14428656 |
| 98 | potassium ion homeostasis (GO:0055075) | 3.13419166 |
| 99 | long term synaptic depression (GO:0060292) | 3.13230040 |
| 100 | postsynaptic membrane organization (GO:0001941) | 3.11842460 |
| 101 | startle response (GO:0001964) | 3.09907220 |
| 102 | iron-sulfur cluster assembly (GO:0016226) | 3.06303904 |
| 103 | metallo-sulfur cluster assembly (GO:0031163) | 3.06303904 |
| 104 | regulation of synaptic transmission (GO:0050804) | 3.06301320 |
| 105 | positive regulation of synaptic transmission (GO:0050806) | 3.05582497 |
| 106 | indolalkylamine metabolic process (GO:0006586) | 3.05141257 |
| 107 | establishment of synaptic vesicle localization (GO:0097480) | 3.04763818 |
| 108 | synaptic vesicle transport (GO:0048489) | 3.04763818 |
| 109 | synaptic transmission, dopaminergic (GO:0001963) | 3.04485122 |
| 110 | drinking behavior (GO:0042756) | 3.03954625 |
| 111 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.03657809 |
| 112 | behavioral response to cocaine (GO:0048148) | 3.03482967 |
| 113 | proline transport (GO:0015824) | 3.01985954 |
| 114 | regulation of neurotransmitter levels (GO:0001505) | 3.01635126 |
| 115 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.01521822 |
| 116 | protein polyglutamylation (GO:0018095) | 3.01212971 |
| 117 | presynaptic membrane organization (GO:0097090) | 3.00667175 |
| 118 | axonal fasciculation (GO:0007413) | 2.99962842 |
| 119 | positive regulation of dendritic spine development (GO:0060999) | 2.98082333 |
| 120 | calcium ion import (GO:0070509) | 2.95196625 |
| 121 | dendrite morphogenesis (GO:0048813) | 2.93641863 |
| 122 | positive regulation of protein homodimerization activity (GO:0090073) | 2.93369549 |
| 123 | mechanosensory behavior (GO:0007638) | 2.91567122 |
| 124 | negative regulation of telomere maintenance (GO:0032205) | 2.91240375 |
| 125 | tryptophan catabolic process (GO:0006569) | 2.88932803 |
| 126 | indole-containing compound catabolic process (GO:0042436) | 2.88932803 |
| 127 | indolalkylamine catabolic process (GO:0046218) | 2.88932803 |
| 128 | regulation of feeding behavior (GO:0060259) | 2.88371801 |
| 129 | positive regulation of amino acid transport (GO:0051957) | 2.84202247 |
| 130 | behavioral response to ethanol (GO:0048149) | 2.83965424 |
| 131 | regulation of action potential (GO:0098900) | 2.83322771 |
| 132 | reflex (GO:0060004) | 2.80731432 |
| 133 | retinal cone cell development (GO:0046549) | 2.79896046 |
| 134 | indole-containing compound metabolic process (GO:0042430) | 2.79444956 |
| 135 | C4-dicarboxylate transport (GO:0015740) | 2.78933355 |
| 136 | piRNA metabolic process (GO:0034587) | 2.78665894 |
| 137 | tryptophan metabolic process (GO:0006568) | 2.78533605 |
| 138 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.74242892 |
| 139 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.73694274 |
| 140 | cellular ketone body metabolic process (GO:0046950) | 2.71478883 |
| 141 | GPI anchor metabolic process (GO:0006505) | 2.70672034 |
| 142 | establishment of mitochondrion localization (GO:0051654) | 2.69460061 |
| 143 | regulation of glutamate secretion (GO:0014048) | 2.66334577 |
| 144 | serotonin metabolic process (GO:0042428) | 2.63949287 |
| 145 | positive regulation of mitochondrial fission (GO:0090141) | 2.63525968 |
| 146 | base-excision repair, AP site formation (GO:0006285) | 2.60837667 |
| 147 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.59657503 |
| 148 | response to auditory stimulus (GO:0010996) | 2.59539246 |
| 149 | negative regulation of cation channel activity (GO:2001258) | 2.57746606 |
| 150 | action potential (GO:0001508) | 2.57562412 |
| 151 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.55515217 |
| 152 | pyrimidine dimer repair (GO:0006290) | 2.54714881 |
| 153 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.54586267 |
| 154 | glycosphingolipid biosynthetic process (GO:0006688) | 2.54033053 |
| 155 | primary amino compound metabolic process (GO:1901160) | 2.53246196 |
| 156 | neural tube formation (GO:0001841) | 2.48787595 |
| 157 | photoreceptor cell maintenance (GO:0045494) | 2.48700232 |
| 158 | regulation of female receptivity (GO:0045924) | 2.48579241 |
| 159 | serotonin receptor signaling pathway (GO:0007210) | 2.48082331 |
| 160 | establishment of protein localization to Golgi (GO:0072600) | 2.47388280 |
| 161 | glycolipid biosynthetic process (GO:0009247) | 2.45062118 |
| 162 | short-chain fatty acid metabolic process (GO:0046459) | 2.44678001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.70126933 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.24600535 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08428334 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02387543 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.98863004 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.86601064 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.66722918 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.64164469 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58289177 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54442027 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54442027 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.52397584 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.51083635 |
| 14 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.49108636 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42438810 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.40293825 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.39045110 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.32773923 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.25046269 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.24593400 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23816371 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.22799740 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.20955978 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18616976 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18546640 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16474882 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.15463214 |
| 28 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.14904271 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.13932487 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.12492083 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.11003111 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.07584125 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.05063727 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.01921806 |
| 35 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.01658172 |
| 36 | * EWS_26573619_Chip-Seq_HEK293_Human | 2.00346370 |
| 37 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96054154 |
| 38 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.94893163 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.85507116 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.81286394 |
| 41 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.79461235 |
| 42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.78134083 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.72757564 |
| 44 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.71073793 |
| 45 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.68149219 |
| 46 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.63748904 |
| 47 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.56649066 |
| 48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.56505379 |
| 49 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.54459561 |
| 50 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.53907184 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.51490432 |
| 52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49576723 |
| 53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46207429 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43369909 |
| 55 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.43335574 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42851890 |
| 57 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.42682913 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42278845 |
| 59 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.41020235 |
| 60 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40433601 |
| 61 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40199408 |
| 62 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38981617 |
| 63 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.38917945 |
| 64 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.38917945 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38147879 |
| 66 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.37576103 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35939195 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35291571 |
| 69 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.33647033 |
| 70 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33179329 |
| 71 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32425769 |
| 72 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.31387286 |
| 73 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.31160269 |
| 74 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30251846 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27818012 |
| 76 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.25428686 |
| 77 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25356780 |
| 78 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.24746759 |
| 79 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.24059658 |
| 80 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23234508 |
| 81 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22765776 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22281120 |
| 83 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22061699 |
| 84 | AR_19668381_ChIP-Seq_PC3_Human | 1.21867790 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21729096 |
| 86 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.21144273 |
| 87 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.20652124 |
| 88 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18998211 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15435879 |
| 90 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.12427466 |
| 91 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12217312 |
| 92 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11841868 |
| 93 | NCOR_22424771_ChIP-Seq_293T_Human | 1.11277601 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09781132 |
| 95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09781132 |
| 96 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09586054 |
| 97 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09538607 |
| 98 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.09500686 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08853246 |
| 100 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.08369212 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08287788 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07094771 |
| 103 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06953188 |
| 104 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05957202 |
| 105 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.05624935 |
| 106 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.05025713 |
| 107 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.04282961 |
| 108 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03937900 |
| 109 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03501426 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03267050 |
| 111 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.03200763 |
| 112 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03128581 |
| 113 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03128581 |
| 114 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02758391 |
| 115 | * JUN_21703547_ChIP-Seq_K562_Human | 1.02218918 |
| 116 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02007290 |
| 117 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01632845 |
| 118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01372255 |
| 119 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01132700 |
| 120 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00802451 |
| 121 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00530248 |
| 122 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.99880407 |
| 123 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99623238 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99502304 |
| 125 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.99239136 |
| 126 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98976274 |
| 127 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.98441539 |
| 128 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.98265076 |
| 129 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98170141 |
| 130 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.97900215 |
| 131 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97731188 |
| 132 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97138433 |
| 133 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97138433 |
| 134 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95874065 |
| 135 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93499295 |
| 136 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92450246 |
| 137 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.91560247 |
| 138 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.91255023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.34364336 |
| 2 | MP0003880_abnormal_central_pattern | 4.73602411 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.07745241 |
| 4 | MP0002822_catalepsy | 3.63897427 |
| 5 | MP0009745_abnormal_behavioral_response | 3.46162641 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.32364070 |
| 7 | MP0002064_seizures | 3.22073663 |
| 8 | MP0004270_analgesia | 3.11141258 |
| 9 | MP0009046_muscle_twitch | 2.99180336 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.84928581 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.79901050 |
| 12 | MP0002272_abnormal_nervous_system | 2.65423538 |
| 13 | MP0001984_abnormal_olfaction | 2.63588197 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.54663543 |
| 15 | MP0001486_abnormal_startle_reflex | 2.51160206 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.48895689 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.26565540 |
| 18 | MP0005551_abnormal_eye_electrophysiolog | 2.22452616 |
| 19 | MP0002736_abnormal_nociception_after | 2.21777333 |
| 20 | MP0005084_abnormal_gallbladder_morpholo | 2.12485316 |
| 21 | MP0003787_abnormal_imprinting | 2.09898967 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.06264389 |
| 23 | MP0001986_abnormal_taste_sensitivity | 1.97001188 |
| 24 | MP0005670_abnormal_white_adipose | 1.95425696 |
| 25 | MP0002184_abnormal_innervation | 1.94694689 |
| 26 | MP0001502_abnormal_circadian_rhythm | 1.94143676 |
| 27 | MP0003879_abnormal_hair_cell | 1.93600524 |
| 28 | MP0000569_abnormal_digit_pigmentation | 1.93570832 |
| 29 | MP0001440_abnormal_grooming_behavior | 1.93117457 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.93059927 |
| 31 | MP0004147_increased_porphyrin_level | 1.88377723 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.86962202 |
| 33 | MP0001970_abnormal_pain_threshold | 1.80652550 |
| 34 | MP0001529_abnormal_vocalization | 1.76929222 |
| 35 | MP0004043_abnormal_pH_regulation | 1.70826681 |
| 36 | MP0001188_hyperpigmentation | 1.68460142 |
| 37 | MP0008569_lethality_at_weaning | 1.68429409 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.65901027 |
| 39 | MP0002557_abnormal_social/conspecific_i | 1.61851804 |
| 40 | MP0002090_abnormal_vision | 1.61785956 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.60055159 |
| 42 | MP0000778_abnormal_nervous_system | 1.56431778 |
| 43 | MP0004811_abnormal_neuron_physiology | 1.56247274 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.55551460 |
| 45 | MP0004924_abnormal_behavior | 1.55551460 |
| 46 | MP0006276_abnormal_autonomic_nervous | 1.52162870 |
| 47 | MP0003329_amyloid_beta_deposits | 1.51345698 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.49432391 |
| 49 | MP0001905_abnormal_dopamine_level | 1.45925447 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.44530126 |
| 51 | MP0000955_abnormal_spinal_cord | 1.41478627 |
| 52 | MP0004142_abnormal_muscle_tone | 1.33879079 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.31590818 |
| 54 | MP0010386_abnormal_urinary_bladder | 1.27369540 |
| 55 | MP0008058_abnormal_DNA_repair | 1.26330330 |
| 56 | MP0004233_abnormal_muscle_weight | 1.26292218 |
| 57 | MP0004858_abnormal_nervous_system | 1.21776516 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 1.20275034 |
| 59 | MP0005410_abnormal_fertilization | 1.18246845 |
| 60 | MP0006072_abnormal_retinal_apoptosis | 1.17091001 |
| 61 | MP0003718_maternal_effect | 1.11808410 |
| 62 | MP0006292_abnormal_olfactory_placode | 1.11259852 |
| 63 | MP0003633_abnormal_nervous_system | 1.10405287 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 1.10317079 |
| 65 | MP0004215_abnormal_myocardial_fiber | 1.10215967 |
| 66 | MP0002229_neurodegeneration | 1.09735562 |
| 67 | MP0002102_abnormal_ear_morphology | 1.08183178 |
| 68 | MP0003122_maternal_imprinting | 1.08164316 |
| 69 | MP0000751_myopathy | 1.06465457 |
| 70 | MP0001346_abnormal_lacrimal_gland | 1.04907347 |
| 71 | MP0002876_abnormal_thyroid_physiology | 1.04558143 |
| 72 | MP0008877_abnormal_DNA_methylation | 1.02871058 |
| 73 | MP0002152_abnormal_brain_morphology | 1.01710273 |
| 74 | MP0005394_taste/olfaction_phenotype | 0.99997161 |
| 75 | MP0005499_abnormal_olfactory_system | 0.99997161 |
| 76 | MP0002752_abnormal_somatic_nervous | 0.99786743 |
| 77 | MP0004885_abnormal_endolymph | 0.99406770 |
| 78 | MP0004085_abnormal_heartbeat | 0.98319690 |
| 79 | MP0002069_abnormal_eating/drinking_beha | 0.96471579 |
| 80 | MP0003631_nervous_system_phenotype | 0.96128648 |
| 81 | MP0008875_abnormal_xenobiotic_pharmacok | 0.96087774 |
| 82 | MP0004145_abnormal_muscle_electrophysio | 0.95499116 |
| 83 | MP0002160_abnormal_reproductive_system | 0.89798741 |
| 84 | MP0000631_abnormal_neuroendocrine_gland | 0.89551260 |
| 85 | MP0008872_abnormal_physiological_respon | 0.88897792 |
| 86 | MP0003136_yellow_coat_color | 0.86464091 |
| 87 | MP0003195_calcinosis | 0.86455895 |
| 88 | MP0002638_abnormal_pupillary_reflex | 0.86100415 |
| 89 | MP0001963_abnormal_hearing_physiology | 0.84369251 |
| 90 | MP0008874_decreased_physiological_sensi | 0.83598872 |
| 91 | MP0003698_abnormal_male_reproductive | 0.83268483 |
| 92 | MP0002928_abnormal_bile_duct | 0.80171468 |
| 93 | MP0001764_abnormal_homeostasis | 0.79615655 |
| 94 | MP0004742_abnormal_vestibular_system | 0.76602972 |
| 95 | MP0000372_irregular_coat_pigmentation | 0.75925541 |
| 96 | MP0005535_abnormal_body_temperature | 0.75661390 |
| 97 | MP0001177_atelectasis | 0.75658909 |
| 98 | MP0000427_abnormal_hair_cycle | 0.75596414 |
| 99 | MP0008995_early_reproductive_senescence | 0.75306000 |
| 100 | MP0005195_abnormal_posterior_eye | 0.74393315 |
| 101 | MP0002837_dystrophic_cardiac_calcinosis | 0.73893406 |
| 102 | MP0008004_abnormal_stomach_pH | 0.73054103 |
| 103 | MP0005389_reproductive_system_phenotype | 0.72912464 |
| 104 | MP0006035_abnormal_mitochondrial_morpho | 0.70432916 |
| 105 | MP0000230_abnormal_systemic_arterial | 0.69939138 |
| 106 | MP0005253_abnormal_eye_physiology | 0.69346218 |
| 107 | MP0003075_altered_response_to | 0.68093897 |
| 108 | MP0003786_premature_aging | 0.68009533 |
| 109 | MP0003634_abnormal_glial_cell | 0.67280948 |
| 110 | MP0005187_abnormal_penis_morphology | 0.67030380 |
| 111 | MP0003632_abnormal_nervous_system | 0.64683549 |
| 112 | MP0004036_abnormal_muscle_relaxation | 0.64249637 |
| 113 | MP0001929_abnormal_gametogenesis | 0.63748922 |
| 114 | MP0000013_abnormal_adipose_tissue | 0.63389445 |
| 115 | MP0001664_abnormal_digestion | 0.63008892 |
| 116 | MP0000604_amyloidosis | 0.62704938 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.61568416 |
| 118 | MP0005595_abnormal_vascular_smooth | 0.61065827 |
| 119 | MP0001293_anophthalmia | 0.60259056 |
| 120 | MP0002332_abnormal_exercise_endurance | 0.60081559 |
| 121 | MP0005409_darkened_coat_color | 0.58556613 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.58545829 |
| 123 | MP0005171_absent_coat_pigmentation | 0.58056011 |
| 124 | MP0002751_abnormal_autonomic_nervous | 0.57791734 |
| 125 | MP0008961_abnormal_basal_metabolism | 0.56149617 |
| 126 | MP0005248_abnormal_Harderian_gland | 0.53853791 |
| 127 | MP0001485_abnormal_pinna_reflex | 0.51440788 |
| 128 | MP0005620_abnormal_muscle_contractility | 0.51168475 |
| 129 | MP0003121_genomic_imprinting | 0.50573719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.85692421 |
| 2 | Myokymia (HP:0002411) | 6.15074355 |
| 3 | Epileptic encephalopathy (HP:0200134) | 5.87335379 |
| 4 | Febrile seizures (HP:0002373) | 5.69358769 |
| 5 | Focal seizures (HP:0007359) | 5.40186633 |
| 6 | Congenital stationary night blindness (HP:0007642) | 4.80271615 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.73869015 |
| 8 | Absence seizures (HP:0002121) | 4.70041287 |
| 9 | Atonic seizures (HP:0010819) | 4.62765329 |
| 10 | Visual hallucinations (HP:0002367) | 4.50520520 |
| 11 | Dialeptic seizures (HP:0011146) | 4.41393876 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.03623181 |
| 13 | Pancreatic cysts (HP:0001737) | 4.02272514 |
| 14 | Pancreatic fibrosis (HP:0100732) | 3.60513054 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.57949329 |
| 16 | Hyperventilation (HP:0002883) | 3.49264314 |
| 17 | Dysdiadochokinesis (HP:0002075) | 3.49062415 |
| 18 | Chronic hepatic failure (HP:0100626) | 3.34010825 |
| 19 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.33094455 |
| 20 | Action tremor (HP:0002345) | 3.20450875 |
| 21 | Nephronophthisis (HP:0000090) | 3.19308821 |
| 22 | Bile duct proliferation (HP:0001408) | 3.17411392 |
| 23 | Abnormal biliary tract physiology (HP:0012439) | 3.17411392 |
| 24 | Scanning speech (HP:0002168) | 3.15838196 |
| 25 | Dysmetria (HP:0001310) | 3.12714844 |
| 26 | Central scotoma (HP:0000603) | 3.12210547 |
| 27 | True hermaphroditism (HP:0010459) | 3.10876367 |
| 28 | Epileptiform EEG discharges (HP:0011182) | 3.10474964 |
| 29 | Hyperglycinemia (HP:0002154) | 3.10081477 |
| 30 | Type II lissencephaly (HP:0007260) | 3.04180850 |
| 31 | Truncal ataxia (HP:0002078) | 3.01048379 |
| 32 | EEG with generalized epileptiform discharges (HP:0011198) | 2.89223201 |
| 33 | Depression (HP:0000716) | 2.87895123 |
| 34 | Broad-based gait (HP:0002136) | 2.87718192 |
| 35 | Amblyopia (HP:0000646) | 2.86346765 |
| 36 | Severe visual impairment (HP:0001141) | 2.77171658 |
| 37 | Abolished electroretinogram (ERG) (HP:0000550) | 2.75913758 |
| 38 | Abnormality of macular pigmentation (HP:0008002) | 2.73895127 |
| 39 | Mutism (HP:0002300) | 2.70740745 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.70670745 |
| 41 | Drooling (HP:0002307) | 2.69603747 |
| 42 | Excessive salivation (HP:0003781) | 2.69603747 |
| 43 | Gait imbalance (HP:0002141) | 2.67017888 |
| 44 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.65956391 |
| 45 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.65956391 |
| 46 | Genetic anticipation (HP:0003743) | 2.63650595 |
| 47 | Abnormality of the renal medulla (HP:0100957) | 2.60559593 |
| 48 | Abnormality of the lower motor neuron (HP:0002366) | 2.60540506 |
| 49 | Anxiety (HP:0000739) | 2.60271134 |
| 50 | Hemiparesis (HP:0001269) | 2.59999562 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.54068790 |
| 52 | Impaired smooth pursuit (HP:0007772) | 2.51058397 |
| 53 | Molar tooth sign on MRI (HP:0002419) | 2.49909703 |
| 54 | Abnormality of midbrain morphology (HP:0002418) | 2.49909703 |
| 55 | Hypsarrhythmia (HP:0002521) | 2.48299552 |
| 56 | Supranuclear gaze palsy (HP:0000605) | 2.46411427 |
| 57 | Torticollis (HP:0000473) | 2.46069104 |
| 58 | Dysmetric saccades (HP:0000641) | 2.44740518 |
| 59 | Poor eye contact (HP:0000817) | 2.41982728 |
| 60 | Absent speech (HP:0001344) | 2.41181225 |
| 61 | Postural instability (HP:0002172) | 2.39819787 |
| 62 | Congenital primary aphakia (HP:0007707) | 2.38979650 |
| 63 | Hypothermia (HP:0002045) | 2.38674263 |
| 64 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.38297701 |
| 65 | Decreased circulating renin level (HP:0003351) | 2.37543358 |
| 66 | Fetal akinesia sequence (HP:0001989) | 2.36355315 |
| 67 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.35877860 |
| 68 | Abnormality of the corticospinal tract (HP:0002492) | 2.33123150 |
| 69 | Tubulointerstitial nephritis (HP:0001970) | 2.33065680 |
| 70 | Cholecystitis (HP:0001082) | 2.32668915 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.32668915 |
| 72 | Impaired social interactions (HP:0000735) | 2.31560901 |
| 73 | Abnormal social behavior (HP:0012433) | 2.31560901 |
| 74 | Absent/shortened dynein arms (HP:0200106) | 2.30993718 |
| 75 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.30993718 |
| 76 | Ankle clonus (HP:0011448) | 2.30713073 |
| 77 | Cystic liver disease (HP:0006706) | 2.30351749 |
| 78 | Diplopia (HP:0000651) | 2.26180935 |
| 79 | Abnormality of binocular vision (HP:0011514) | 2.26180935 |
| 80 | Focal dystonia (HP:0004373) | 2.25486155 |
| 81 | Nephrogenic diabetes insipidus (HP:0009806) | 2.24822337 |
| 82 | Impaired vibratory sensation (HP:0002495) | 2.23838169 |
| 83 | Medial flaring of the eyebrow (HP:0010747) | 2.23411374 |
| 84 | Protruding tongue (HP:0010808) | 2.19491679 |
| 85 | Attenuation of retinal blood vessels (HP:0007843) | 2.17204429 |
| 86 | Metaphyseal dysplasia (HP:0100255) | 2.14573286 |
| 87 | Incomplete penetrance (HP:0003829) | 2.13679219 |
| 88 | Progressive inability to walk (HP:0002505) | 2.13192046 |
| 89 | Polyphagia (HP:0002591) | 2.12674381 |
| 90 | Septo-optic dysplasia (HP:0100842) | 2.12295541 |
| 91 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.12075521 |
| 92 | Lissencephaly (HP:0001339) | 2.11241513 |
| 93 | Failure to thrive in infancy (HP:0001531) | 2.10425397 |
| 94 | Spastic gait (HP:0002064) | 2.10056329 |
| 95 | Bradykinesia (HP:0002067) | 2.08399160 |
| 96 | Abnormality of the labia minora (HP:0012880) | 2.06098196 |
| 97 | Methylmalonic acidemia (HP:0002912) | 2.03511777 |
| 98 | Abnormality of the renal cortex (HP:0011035) | 2.02225589 |
| 99 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.00854641 |
| 100 | Gait ataxia (HP:0002066) | 1.99598266 |
| 101 | Stereotypic behavior (HP:0000733) | 1.99444185 |
| 102 | Craniofacial dystonia (HP:0012179) | 1.98324658 |
| 103 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.98296127 |
| 104 | Hemiplegia (HP:0002301) | 1.97742169 |
| 105 | Ventricular fibrillation (HP:0001663) | 1.97314461 |
| 106 | Generalized myoclonic seizures (HP:0002123) | 1.96955217 |
| 107 | Inability to walk (HP:0002540) | 1.96466562 |
| 108 | Colon cancer (HP:0003003) | 1.96410331 |
| 109 | Optic nerve hypoplasia (HP:0000609) | 1.96068359 |
| 110 | Thyroid-stimulating hormone excess (HP:0002925) | 1.94991049 |
| 111 | Specific learning disability (HP:0001328) | 1.94932588 |
| 112 | Mitochondrial inheritance (HP:0001427) | 1.94276892 |
| 113 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.94005170 |
| 114 | Status epilepticus (HP:0002133) | 1.93971575 |
| 115 | Urinary urgency (HP:0000012) | 1.92992887 |
| 116 | Poor coordination (HP:0002370) | 1.91524317 |
| 117 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.90956173 |
| 118 | Abnormality of glycine metabolism (HP:0010895) | 1.90956173 |
| 119 | Abnormal hair whorl (HP:0010721) | 1.89953647 |
| 120 | Stomach cancer (HP:0012126) | 1.89623989 |
| 121 | Pheochromocytoma (HP:0002666) | 1.88563908 |
| 122 | Increased circulating renin level (HP:0000848) | 1.88455729 |
| 123 | Abnormal EKG (HP:0003115) | 1.88132351 |
| 124 | Limb ataxia (HP:0002070) | 1.86587267 |
| 125 | Thickened helices (HP:0000391) | 1.86364376 |
| 126 | Genital tract atresia (HP:0001827) | 1.85529411 |
| 127 | Congenital hepatic fibrosis (HP:0002612) | 1.85428774 |
| 128 | Neuronal loss in central nervous system (HP:0002529) | 1.83540895 |
| 129 | Prolonged QT interval (HP:0001657) | 1.82754021 |
| 130 | Retinal dysplasia (HP:0007973) | 1.82516960 |
| 131 | Hypoplasia of the brainstem (HP:0002365) | 1.82259361 |
| 132 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.82259361 |
| 133 | Hepatocellular necrosis (HP:0001404) | 1.82232203 |
| 134 | Blue irides (HP:0000635) | 1.82087429 |
| 135 | Supernumerary spleens (HP:0009799) | 1.81705059 |
| 136 | Vaginal atresia (HP:0000148) | 1.80809538 |
| 137 | Decreased central vision (HP:0007663) | 1.80538692 |
| 138 | Pendular nystagmus (HP:0012043) | 1.78994581 |
| 139 | Abnormality of salivation (HP:0100755) | 1.78718949 |
| 140 | Postaxial foot polydactyly (HP:0001830) | 1.78491146 |
| 141 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.77937573 |
| 142 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.77937573 |
| 143 | Abnormality of saccadic eye movements (HP:0000570) | 1.77827566 |
| 144 | Poor suck (HP:0002033) | 1.77345373 |
| 145 | Limb dystonia (HP:0002451) | 1.76905466 |
| 146 | Agitation (HP:0000713) | 1.76796067 |
| 147 | Acute lymphatic leukemia (HP:0006721) | 1.76547117 |
| 148 | CNS hypomyelination (HP:0003429) | 1.75015296 |
| 149 | Widely spaced teeth (HP:0000687) | 1.74904806 |
| 150 | Hypoventilation (HP:0002791) | 1.74580031 |
| 151 | Scotoma (HP:0000575) | 1.72943987 |
| 152 | Clumsiness (HP:0002312) | 1.72830509 |
| 153 | Intention tremor (HP:0002080) | 1.72151531 |
| 154 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.71853543 |
| 155 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.71669081 |
| 156 | Tubulointerstitial abnormality (HP:0001969) | 1.71614607 |
| 157 | Cerebellar dysplasia (HP:0007033) | 1.71148643 |
| 158 | Abnormality of alanine metabolism (HP:0010916) | 1.70418808 |
| 159 | Hyperalaninemia (HP:0003348) | 1.70418808 |
| 160 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.70418808 |
| 161 | Hepatic necrosis (HP:0002605) | 1.70081152 |
| 162 | Termporal pattern (HP:0011008) | 1.69473011 |
| 163 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.69265519 |
| 164 | Renal cortical cysts (HP:0000803) | 1.68236841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.65643906 |
| 2 | EPHA4 | 4.66476272 |
| 3 | MAP3K9 | 3.42511027 |
| 4 | MAP3K4 | 3.10123871 |
| 5 | FRK | 3.08413441 |
| 6 | MAP2K7 | 2.75357775 |
| 7 | MAP4K2 | 2.68075695 |
| 8 | PRPF4B | 2.56411190 |
| 9 | MINK1 | 2.46660024 |
| 10 | PAK6 | 2.34223676 |
| 11 | TNIK | 2.34081724 |
| 12 | KSR2 | 2.23382393 |
| 13 | MARK1 | 2.15025875 |
| 14 | KSR1 | 2.08053337 |
| 15 | TAOK3 | 2.00733374 |
| 16 | ADRBK2 | 1.99207303 |
| 17 | NME1 | 1.98410189 |
| 18 | ARAF | 1.97678085 |
| 19 | MAP3K13 | 1.90812817 |
| 20 | GRK1 | 1.87793809 |
| 21 | DAPK2 | 1.81265055 |
| 22 | CASK | 1.77666792 |
| 23 | EIF2AK3 | 1.68048776 |
| 24 | NTRK2 | 1.66579267 |
| 25 | MAP2K4 | 1.60518558 |
| 26 | CSNK1G3 | 1.57576884 |
| 27 | FES | 1.54253361 |
| 28 | ZAK | 1.52216514 |
| 29 | CSNK1A1L | 1.48262030 |
| 30 | DAPK1 | 1.45116242 |
| 31 | PLK2 | 1.40818130 |
| 32 | TRIM28 | 1.39853392 |
| 33 | MAPKAPK3 | 1.38364451 |
| 34 | MAPK13 | 1.37564647 |
| 35 | CDK5 | 1.34931272 |
| 36 | PRKD3 | 1.31882233 |
| 37 | DYRK2 | 1.28752689 |
| 38 | CDK19 | 1.27308801 |
| 39 | CSNK1G1 | 1.26470407 |
| 40 | STK38 | 1.22502685 |
| 41 | TXK | 1.22426924 |
| 42 | GRK5 | 1.21958438 |
| 43 | TESK2 | 1.21134004 |
| 44 | PRKCG | 1.20879004 |
| 45 | MAP3K12 | 1.17432400 |
| 46 | BCKDK | 1.17350413 |
| 47 | RIPK4 | 1.16715581 |
| 48 | NUAK1 | 1.16077596 |
| 49 | CAMK2A | 1.16071913 |
| 50 | AKT3 | 1.15601594 |
| 51 | CAMKK1 | 1.15223722 |
| 52 | BMPR1B | 1.14630827 |
| 53 | CAMK2B | 1.13646916 |
| 54 | ERBB3 | 1.08069804 |
| 55 | SGK223 | 1.07936046 |
| 56 | SGK494 | 1.07936046 |
| 57 | DYRK1A | 1.06061613 |
| 58 | SGK2 | 1.02592805 |
| 59 | RAF1 | 1.02579044 |
| 60 | FLT3 | 1.00946509 |
| 61 | CAMK1 | 1.00517849 |
| 62 | BRAF | 1.00119734 |
| 63 | PHKG1 | 0.99624053 |
| 64 | PHKG2 | 0.99624053 |
| 65 | CAMKK2 | 0.99622464 |
| 66 | TAOK2 | 0.93881275 |
| 67 | PTK2B | 0.90621033 |
| 68 | CDK18 | 0.90583141 |
| 69 | CDK14 | 0.89530082 |
| 70 | NTRK1 | 0.89475215 |
| 71 | TLK1 | 0.89177005 |
| 72 | TEC | 0.89041768 |
| 73 | CAMK2D | 0.88982896 |
| 74 | MAP3K2 | 0.88503547 |
| 75 | PAK3 | 0.87792177 |
| 76 | CDK15 | 0.85626151 |
| 77 | MUSK | 0.85117984 |
| 78 | SIK3 | 0.82484470 |
| 79 | OXSR1 | 0.79589037 |
| 80 | NEK1 | 0.78165383 |
| 81 | MAP3K7 | 0.77212015 |
| 82 | PNCK | 0.75931141 |
| 83 | MAP3K6 | 0.75599597 |
| 84 | PINK1 | 0.74759825 |
| 85 | CDK11A | 0.72816411 |
| 86 | BMPR2 | 0.72799890 |
| 87 | FER | 0.72493301 |
| 88 | SGK1 | 0.71930263 |
| 89 | SIK2 | 0.71582743 |
| 90 | RPS6KA4 | 0.71284869 |
| 91 | PRKCE | 0.69893661 |
| 92 | RPS6KA5 | 0.69632598 |
| 93 | WNK3 | 0.68690536 |
| 94 | VRK1 | 0.68463130 |
| 95 | CDK3 | 0.66720976 |
| 96 | SGK3 | 0.65334651 |
| 97 | PIK3CA | 0.65060588 |
| 98 | SRPK1 | 0.63808546 |
| 99 | STK11 | 0.63739585 |
| 100 | TIE1 | 0.62933008 |
| 101 | UHMK1 | 0.62556542 |
| 102 | TNK2 | 0.61445058 |
| 103 | KDR | 0.60692316 |
| 104 | LATS2 | 0.59243145 |
| 105 | MAP2K1 | 0.59107862 |
| 106 | MAP3K1 | 0.58157092 |
| 107 | KIT | 0.57478382 |
| 108 | CSNK1A1 | 0.57461863 |
| 109 | CAMK2G | 0.57264635 |
| 110 | MARK2 | 0.57128220 |
| 111 | ADRBK1 | 0.54408621 |
| 112 | PRKCH | 0.53703029 |
| 113 | ITK | 0.53186477 |
| 114 | IRAK2 | 0.53027669 |
| 115 | PLK4 | 0.53020067 |
| 116 | PKN1 | 0.52894634 |
| 117 | CDK8 | 0.52120022 |
| 118 | SYK | 0.49330203 |
| 119 | MAP2K6 | 0.49055504 |
| 120 | CSNK1G2 | 0.47514751 |
| 121 | RPS6KA3 | 0.46811115 |
| 122 | MAP3K5 | 0.46616039 |
| 123 | STK16 | 0.46149336 |
| 124 | PDK1 | 0.45666298 |
| 125 | PRKCQ | 0.45138290 |
| 126 | CDC7 | 0.45006814 |
| 127 | ACVR1B | 0.43389397 |
| 128 | PRKCB | 0.43039895 |
| 129 | RET | 0.42854159 |
| 130 | PRKCZ | 0.41693079 |
| 131 | CAMK1G | 0.41618444 |
| 132 | CSNK1D | 0.41499209 |
| 133 | LMTK2 | 0.41071845 |
| 134 | MKNK1 | 0.40748001 |
| 135 | CAMK4 | 0.40617172 |
| 136 | TAOK1 | 0.40301134 |
| 137 | NEK6 | 0.39575053 |
| 138 | PRKACA | 0.38966445 |
| 139 | PRKCA | 0.38847842 |
| 140 | PDPK1 | 0.38694942 |
| 141 | MOS | 0.38657907 |
| 142 | PRKG1 | 0.38491814 |
| 143 | CDC42BPA | 0.38177458 |
| 144 | DYRK3 | 0.38113032 |
| 145 | CSNK1E | 0.37834531 |
| 146 | MKNK2 | 0.37483387 |
| 147 | CCNB1 | 0.36680525 |
| 148 | BCR | 0.35822022 |
| 149 | INSRR | 0.35061527 |
| 150 | MAPKAPK5 | 0.34897620 |
| 151 | TYRO3 | 0.34586318 |
| 152 | PRKACB | 0.34421552 |
| 153 | FGR | 0.34288610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.62635677 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.68477864 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 3.23941582 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.20939993 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.98270556 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.92098990 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.71609507 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.58800192 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.47824204 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.38775050 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.35048204 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.26910603 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.14436792 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.10681529 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 2.08140739 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 2.05847643 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.99122526 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.92887371 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.92842509 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.85767636 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.85001858 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.76688958 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.75901800 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.74954351 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.73499085 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.70386014 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.69620986 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.64937807 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.59341055 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.50708449 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.48859857 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.45552970 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.43776929 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.41455733 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.37285620 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.33219415 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.33208165 |
| 38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.30089995 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29578796 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29020173 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27459789 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.24422759 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.24358332 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23520194 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.22168176 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 1.21309121 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20841069 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.19659527 |
| 49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17530241 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 1.15431893 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 1.14627490 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14385542 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12097616 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.09182121 |
| 55 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.08763624 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08649196 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06168764 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00040831 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98319804 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.94838560 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.93532202 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92603035 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 0.90338799 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89003654 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.85218740 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85186954 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85179938 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84964104 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.82185553 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80810846 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.80754047 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80733589 |
| 73 | Huntingtons disease_Homo sapiens_hsa05016 | 0.80366863 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77903015 |
| 75 | RNA polymerase_Homo sapiens_hsa03020 | 0.74111023 |
| 76 | Protein export_Homo sapiens_hsa03060 | 0.73992207 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73142125 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71541633 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71057337 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.68155679 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67821946 |
| 82 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64639334 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64598517 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64589938 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64536074 |
| 86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63216564 |
| 87 | RNA transport_Homo sapiens_hsa03013 | 0.61691960 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60812478 |
| 89 | Purine metabolism_Homo sapiens_hsa00230 | 0.60578617 |
| 90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59714503 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.56843901 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56204963 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55883374 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55404049 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54721728 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53984385 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.51792858 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51275996 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51200445 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51195531 |
| 101 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50999743 |
| 102 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.50806312 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50786658 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50596351 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50433254 |
| 106 | Alzheimers disease_Homo sapiens_hsa05010 | 0.50424565 |
| 107 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49222520 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48494583 |
| 109 | Proteasome_Homo sapiens_hsa03050 | 0.48012146 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46646587 |
| 111 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46523136 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.45640642 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45161958 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44332785 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40675177 |
| 116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39994547 |
| 117 | Base excision repair_Homo sapiens_hsa03410 | 0.39455490 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38710450 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38645930 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37844599 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36774304 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36570337 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36440096 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35307148 |
| 125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34378745 |
| 126 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.34262920 |
| 127 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33699949 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33643499 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33361330 |
| 130 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31786029 |
| 131 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.30755956 |
| 132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.30403628 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29849680 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29786797 |
| 135 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28500584 |
| 136 | Prion diseases_Homo sapiens_hsa05020 | 0.27473781 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26937662 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.26134191 |
| 139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25222738 |
| 140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24377421 |
| 141 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23153489 |
| 142 | Bile secretion_Homo sapiens_hsa04976 | 0.23026170 |
| 143 | Melanoma_Homo sapiens_hsa05218 | 0.22672761 |
| 144 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21700880 |
| 145 | Endocytosis_Homo sapiens_hsa04144 | 0.20836516 |
| 146 | Parkinsons disease_Homo sapiens_hsa05012 | 0.20451110 |
| 147 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20257438 |

